Explore recent advancements in low-density lipoprotein cholesterol (LDL-C) management, examining the latest therapeutic options, supporting clinical evidence, and updated guidelines for optimising patient care and reducing cardiovascular risk.
This is a RACGP CPD module with an allocated 0.5 hour of Education Activities (EA), 5 hours of Measuring Outcomes (MO), and 1 hour of Reflective Practice (RP) under the RACGP 2023-25 CPD program.
Learning Objectives:
- Review updated lipid targets
- Discuss residual LDL-C-related cardiovascular risk evaluation and management
- Review recent CV outcomes trials with addition of non-statin medication to statin therapy
- Identify groups of patients who have demonstrated benefit with non-statin therapies
This activity is presented by Dr David Chandrakumar, a Cardiologist at the Norwest Private Hospital. Dr Chandrakumar is trained in all aspects of general cardiology, but has a special interest in non-invasive imaging, including CT coronary angiography, and heart failure, with a predominant focus on the management of patients undergoing cancer therapy.
This presentation was recorded in April 2024.
*If you’d like to watch this presentation alone without doing the CPD Activity, click here.
